Chemical Structure-visudyne (Image 01)
Visudyne Injection, Powder, Lyophilized, For Solution
Product Images NDC 0187-5600
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Visudyne (NDC 0187-5600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Visudyne is a medication intended for intravenous injection. It contains 2mg of active ingredient erteporfin and several inactive components, including ascorbyl palmitate, butylated hydroxytoluene, dimyristoyl phosphatidylcholine, egg phosphatidylglycerol and lactose. Storage temperature should be kept between 20°C to 25°C (68°F to 77°F) and reconstituted Visudyne should be used within 4 hours, while being protected from light. Dosage and prescribing instructions can be found in the package insert. The medication is delivered as a single-use vial and distributed by Bausch + Lomb, a division of Bausch Health US, LLC. The product is manufactured by Alcami Carolinas Corporation in Charleston, SC, and Visudyne is the registered trademark of CHEPLAPHARM ARZNEIMITTEL GMBH used under license.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
